Gain Therapeutics, Inc. (NASDAQ:GANX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dov Goldstein Other companies: BioAge Labs, Inc. (Chief Financial Officer · Since at least Sep 25, 2024); Coya Therapeutics, Inc. (Director · Since at least Dec 28, 2022); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Loxo Oncology Inc (CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past) | Independent Member · Since at least Mar 17, 2021 |
| Gwen Melincoff Other companies: Chemomab Therapeutics Ltd. (Board Director · Since at least Jun 1, 2026); Protalix BioTherapeutics, Inc. (de) (Director · Since at least Jan 1, 2020); Soleno Therapeutics, Inc. (Director · Apr 26, 2019 – May 25, 2023 · Past); Collegium Pharmaceutical, Inc. (Director · Aug 9, 2017 – May 16, 2024 · Past); Tobira Therapeutics Inc (Director · May 4, 2015 – Nov 1, 2016 · Past) | Independent Member · Since at least Mar 17, 2021 |
| Charles Evan Ballantyne Other companies: Agenus Inc. (CFO · Jun 17, 2015 – Jun 14, 2016 · Past); Theriva Biologics, Inc. (Chief Financial Officer · Feb 6, 2012 – Jan 8, 2015 · Past); Clinical Data Inc (EVP, CFO · Jun 14, 2007 – Apr 12, 2011 · Past) | Chief Financial Officer · Apr 10, 2023 – Apr 10, 2023 · Past |
| Claude Nicaise Other companies: Filana Therapeutics, Inc. (Independent Director, Chairman of the Board · Since at least Dec 6, 2023); Chemomab Therapeutics Ltd. (Board Director · Since at least Mar 16, 2021); Sarepta Therapeutics, Inc. (Director · Since at least Jun 2, 2015) | Independent Member · Since at least Mar 17, 2021 |
| Khalid Islam Other companies: Fennec Pharmaceuticals Inc. (Chairman · Since at least Sep 11, 2017); Processa Pharmaceuticals, Inc. (Director · Nov 3, 2020 – Mar 31, 2022 · Past); Immunomedics Inc (Director · Mar 13, 2017 – Oct 23, 2020 · Past) | Chairman · Since at least Mar 17, 2021 |
| Eric I Richman Other companies: NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); ADMA Biologics Inc (Director · Nov 9, 2017 – Feb 28, 2020 · Past) | Director · Since at least Mar 17, 2021 |
| Hans Peter Hasler Other companies: Minerva Neurosciences, Inc (Member · Since at least Dec 10, 2017); Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past) | Director · Since at least Mar 17, 2021 |
| Gene Mack Other companies: SELLAS Life Sciences Group, Inc. (CFO and Treasurer · Apr 20, 2018 – Apr 20, 2018 · Past) | Chief Executive Officer · Since at least Apr 5, 2024 |
| Jeffrey Riley Other companies: Theriva Biologics, Inc. (Chief Executive Officer, Director · Mar 16, 2010 – Nov 30, 2016 · Past) | Independent Member · Since at least Mar 17, 2021 |
| Matthias Alder Other companies: Sucampo Pharmaceuticals Inc (EVP, Gen. Council & Sec. · Mar 4, 2015 – Jun 30, 2017 · Past) | Chief Executive Officer, Director · Dec 23, 2021 – Mar 26, 2024 · Past |
| Apaar Jammu | Director, Investor Relations and Public Relations · Since at least Oct 8, 2026 |
| Gianluca Fuggetta | See Remark · Since at least Dec 12, 2022 |
| Investors:Gain Therapeutics | Inc. Apaar Jammu Director, Investor Relations and Public · Since at least Oct 1, 2026 |
| Manolo Bellotto | President and General Manager · Mar 17, 2021 – Mar 17, 2021 · Past |
| Salvatore Calabrese | Chief Financial Officer · Mar 17, 2021 – Mar 23, 2023 · Past |